The healthcare world is witnessing a significant shift in diabetes treatment with the emergence of GLP-1 skin applications. These systems offer a seemingly more user-friendly alternative to shots of GLP-1 medications, lessening the need for daily needle pricks. The innovation administers the drug directly through the epidermis, arguably improving i